Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dydrogesterone versus GnRH antagonist protocol in IVF cycles
IRCT20181031041519N2Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jun 2019
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dydrogesterone, cetrorelix, triptorelin and human menopausal gonadotrophin in female infertility (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Number of mature oocytes and LH surge. Started Jun 2019; status: completed.
02
Drugs
dydrogesteronecetrorelixtriptorelinhuman menopausal gonadotrophin
03
Conditions
female infertility
Beyond the preview
Go deeper on IRCT20181031041519N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181031041519N2.